These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 8428365

  • 1. Reshaping a human antibody to inhibit the interleukin 6-dependent tumor cell growth.
    Sato K, Tsuchiya M, Saldanha J, Koishihara Y, Ohsugi Y, Kishimoto T, Bendig MM.
    Cancer Res; 1993 Feb 15; 53(4):851-6. PubMed ID: 8428365
    [Abstract] [Full Text] [Related]

  • 2. Humanization of an anti-human IL-6 mouse monoclonal antibody glycosylated in its heavy chain variable region.
    Sato K, Ohtomo T, Hirata Y, Saito H, Matsuura T, Akimoto T, Akamatsu K, Koishihara Y, Ohsugi Y, Tsuchiya M.
    Hum Antibodies Hybridomas; 1996 Feb 15; 7(4):175-83. PubMed ID: 9140729
    [Abstract] [Full Text] [Related]

  • 3. cDNA cloning and sequencing of a novel monoclonal antibody to carcinoembryonic antigen and construction of a mouse/human chimeric antibody.
    Shibaguchi H, Arakawa F, Imakiire T, Kuroki M, Kuroki M.
    Anticancer Res; 2003 Feb 15; 23(6a):4383-8. PubMed ID: 14666725
    [Abstract] [Full Text] [Related]

  • 4. Binding activities and antitumor properties of a new mouse/human chimeric antibody specific for GD2 ganglioside antigen.
    Alvarez-Rueda N, Leprieur S, Clémenceau B, Supiot S, Sébille-Rivain V, Faivre-Chauvet A, Davodeau F, Paris F, Barbet J, Aubry J, Birklé S.
    Clin Cancer Res; 2007 Sep 15; 13(18 Pt 2):5613s-5620s. PubMed ID: 17875797
    [Abstract] [Full Text] [Related]

  • 5. A novel domain antibody rationally designed against TNF-alpha using variable region of human heavy chain antibody as scaffolds to display antagonistic peptides.
    Qin W, Feng J, Li Y, Lin Z, Shen B.
    Mol Immunol; 2007 Mar 15; 44(9):2355-61. PubMed ID: 17125837
    [Abstract] [Full Text] [Related]

  • 6. Engineered anti-CD38 monoclonal antibodies for immunotherapy of multiple myeloma.
    Ellis JH, Barber KA, Tutt A, Hale C, Lewis AP, Glennie MJ, Stevenson GT, Crowe JS.
    J Immunol; 1995 Jul 15; 155(2):925-37. PubMed ID: 7608568
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Construction of expression vector for human-mouse chimeric antibody and expression of an antibody against human HER2].
    Wang LL, Han H.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 May 15; 20(3):363-5. PubMed ID: 15193240
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Humanization by variable domain resurfacing and grafting on a human IgG4, using a new approach for determination of non-human like surface accessible framework residues based on homology modelling of variable domains.
    Staelens S, Desmet J, Ngo TH, Vauterin S, Pareyn I, Barbeaux P, Van Rompaey I, Stassen JM, Deckmyn H, Vanhoorelbeke K.
    Mol Immunol; 2006 Mar 15; 43(8):1243-57. PubMed ID: 16118019
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.